CRSP insider filings

CRISPR Therapeutics AG — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen CRSP transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 17 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Kulkarni Samarth — Chief Executive Officer, Director4—2 legs · 51,935 sh · $2,583,1937
KASINGER JAMES R. — General Counsel and Secretary4—3 legs · 13,430 sh · $797,1718
Behbahani Ali — Director2—1 leg · 13,679 sh · $780,9354
George Simeon — Director1—1 leg · 14,514 sh · $720,3732
Silver Andrew Jacob — Chief Financial Officer3——3
Patel Naimish — Chief Medical Officer1——2
Sakhamuri Sivakesava — Chief Technical Officer2——2

Recent insider filings — CRISPR Therapeutics AG

FiledFormInsiderReported transactionsSource
2026-11-194Kulkarni Samarth — Chief Executive Officer, DirectorGift (G): 100,000 @ $0EDGAR
2026-11-064Sakhamuri Sivakesava — Chief Technical OfficerGrant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-11-023Sakhamuri Sivakesava — Chief Technical OfficerHoldings only — no transactions reportedEDGAR
2026-10-284Silver Andrew Jacob — Chief Financial OfficerGrant/award (A): 18,000 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2026-10-284KASINGER JAMES R. — General Counsel and SecretaryGrant/award (A): 18,000 (derivative) @ $0 · Grant/award (A): 9,000 (derivative) @ $0EDGAR
2026-10-284Patel Naimish — Chief Medical OfficerGrant/award (A): 24,000 (derivative) @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2026-10-284Kulkarni Samarth — Chief Executive Officer, DirectorGrant/award (A): 57,500 (derivative) @ $0 · Grant/award (A): 28,750 (derivative) @ $0EDGAR
2026-10-214Silver Andrew Jacob — Chief Financial OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-10-213Silver Andrew Jacob — Chief Financial OfficerHoldings only — no transactions reportedEDGAR
2026-10-204Kulkarni Samarth — Chief Executive Officer, DirectorOption exercise (M): 100,000 · Sale (S): 47,837 @ $49.78 · Option exercise (M): 100,000 (derivative)EDGAR
2026-10-164George Simeon — DirectorOption exercise (M): 30,000 @ $14 · Sale (S): 14,514 @ $49.63 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2026-10-154Kulkarni Samarth — Chief Executive Officer, DirectorOption exercise (M): 8,333 · Sale (S): 4,098 @ $49.26 · Option exercise (M): 8,333 (derivative)EDGAR
2026-10-154KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 2,113 · Sale (S): 1,040 @ $49.26 · Option exercise (M): 2,113 (derivative)EDGAR
2026-10-084KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 1,990 @ $13.62 · Sale (S): 1,990 @ $60.04 · Option exercise (M): 1,990 (derivative) @ $0EDGAR
2026-09-244KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 10,400 @ $13.62 · Sale (S): 10,400 @ $60.24 · Option exercise (M): 10,400 (derivative) @ $0EDGAR
2026-09-214Behbahani Ali — DirectorOption exercise (M): 30,000 @ $14 · Sale (S): 13,679 @ $57.09 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2026-09-214Behbahani Ali — DirectorOther (J): 60 @ $0 · Other (J): 15 @ $0EDGAR
2026-08-114Prasad Raju — Chief Financial OfficerGift (G): 750 @ $0EDGAR
2026-06-094Fleming Harold Edward — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Rommel Christian — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Treco Douglas A — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Morrison Briggs — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094High Katherine A — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Behbahani Ali — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Greene John — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094George Simeon — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Fardis Maria — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-094Mahatme Sandesh — DirectorGrant/award (A): 13,000 (derivative) @ $0EDGAR
2026-06-024KASINGER JAMES R. — General Counsel and SecretaryGrant/award (A): 17,000 (derivative) @ $0EDGAR
2026-06-024Patel Naimish — Chief Medical OfficerGrant/award (A): 22,000 (derivative) @ $0EDGAR
2026-06-024Prasad Raju — Chief Financial OfficerGrant/award (A): 19,500 (derivative) @ $0EDGAR
2026-06-014Patel Naimish — Chief Medical OfficerOption exercise (M): 10,000 · Sale (S): 3,786 @ $55.62 · Option exercise (M): 10,000 (derivative)EDGAR
2026-03-244KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 6,250 · Sale (S): 3,182 @ $46.78 · Grant/award (A): 38,499 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Option exercise (M): 6,250 (derivative)EDGAR
2026-03-244Kulkarni Samarth — Chief Executive Officer, DirectorOption exercise (M): 19,687 · Sale (S): 10,020 @ $46.78 · Grant/award (A): 114,249 (derivative) @ $0 · Grant/award (A): 81,875 (derivative) @ $0 · Option exercise (M): 19,687 (derivative)EDGAR
2026-03-244Prasad Raju — Chief Financial OfficerOption exercise (M): 6,250 · Sale (S): 3,708 @ $46.78 · Grant/award (A): 38,499 (derivative) @ $0 · Grant/award (A): 27,500 (derivative) @ $0 · Option exercise (M): 6,250 (derivative)EDGAR
2026-03-244Patel Naimish — Chief Medical OfficerGrant/award (A): 38,499 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-03-174Patel Naimish — Chief Medical OfficerOption exercise (M): 8,125 · Sale (S): 3,150 @ $48.26 · Option exercise (M): 8,125 (derivative)EDGAR
2026-03-174Prasad Raju — Chief Financial OfficerOption exercise (M): 10,000 · Option exercise (M): 6,875 · Sale (S): 5,848 @ $48.26 · Sale (S): 4,021 @ $48.26 · Gift (G): 750 @ $0 · Option exercise (M): 10,000 (derivative) · +1 moreEDGAR
2026-03-174KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 6,875 · Sale (S): 3,450 @ $48.26 · Option exercise (M): 6,875 (derivative)EDGAR
2026-03-174Kulkarni Samarth — Chief Executive Officer, DirectorOption exercise (M): 20,625 · Sale (S): 10,349 @ $48.26 · Option exercise (M): 20,625 (derivative)EDGAR
2026-03-124KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 5,500 · Sale (S): 2,800 @ $52.80 · Option exercise (M): 5,500 (derivative)EDGAR
2026-03-124Kulkarni Samarth — Chief Executive Officer, DirectorOption exercise (M): 19,250 · Sale (S): 9,798 @ $52.80 · Option exercise (M): 19,250 (derivative)EDGAR
2026-02-204Kulkarni Samarth — Chief Executive Officer, DirectorOption exercise (M): 13,250 · Sale (S): 6,967 @ $52.58 · Option exercise (M): 13,250 (derivative)EDGAR
2026-02-204KASINGER JAMES R. — General Counsel and SecretaryOption exercise (M): 3,825 · Sale (S): 2,112 @ $52.58 · Option exercise (M): 3,825 (derivative)EDGAR
2026-01-274Patel Naimish — Chief Medical OfficerPurchase (P): 1,508 @ $32.96EDGAR
2026-01-264Prasad Raju — Chief Financial OfficerOption exercise (M): 34,972 @ $45.15 · Sale (S): 34,972 @ $60.19 · Option exercise (M): 34,972 (derivative) @ $0EDGAR
2026-01-224Kulkarni Samarth — Chief Executive Officer, DirectorSale (S): 21,433 @ $51.61 · Sale (S): 8,567 @ $52.10 · Sale (S): 60,000 @ $60.23EDGAR
2026-01-084Prasad Raju — Chief Financial OfficerOption exercise (M): 23,361 @ $45.15 · Option exercise (M): 6,339 @ $44.31 · Sale (S): 18,933 @ $60.18 · Sale (S): 5,004 @ $60 · Sale (S): 5,763 @ $60.21 · Option exercise (M): 23,361 (derivative) @ $0 · +1 moreEDGAR
2025-12-234Prasad Raju — Chief Financial OfficerSale (S): 3,528 @ $55.10 · Sale (S): 5,472 @ $56.33 · Sale (S): 1,000 @ $56.89EDGAR
2025-12-224Kulkarni Samarth — Chief Executive Officer, DirectorGift (G): 30,000 @ $0EDGAR

Recent 8-K events — CRISPR Therapeutics AG

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-028-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-168-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-118-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-128-K8.01 — Other EventsEDGAR
2025-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CRSP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs